Praluent

Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Amgen
Sanofi
Regeneron
Supreme Court
legal
innovation
patents
Repatha
Praluent
Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme
Fierce Pharma
Wed, 06/1/22 - 07:36 pm
Regeneron
Amgen
FDA
antitrust
legal
Repatha
Praluent
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
BioSpace
Mon, 11/15/21 - 11:55 pm
Merck
PCSK9 inhibitors
Amgen
Repatha
Esperion
Sanofi
Regeneron
Praluent
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Endpoints
Fri, 02/12/21 - 10:48 am
Amgen
patents
Sanofi
Regeneron
Praluent
Repatha
Merck
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
Sun, 08/30/20 - 11:25 pm
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
Two Big Drug Flops Show How Health-Care Economics Have Changed
Bloomberg
Fri, 01/10/20 - 10:34 am
drug pricing
Sanofi
Amgen
Praluent
Repatha
MedCo's PCSK9 challenger steals the show at ESC with winning data
Fierce Pharma
Mon, 09/2/19 - 12:27 pm
Medicines Company
ESC
PCSK9 inhibitors
inclisiran
Repatha
Praluent
European Society of Cardiology
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Wed, 08/28/19 - 10:52 pm
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Praluent
Repatha
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Fierce Pharma
Tue, 08/27/19 - 12:04 pm
Amgen
Regeneron
Sanofi
Praluent
Repatha
Medicines Company
PCSK9 inhibitors
inclisiran
German court blocks sale of Sanofi, Regeneron cholesterol drug
Biopharma Dive
Thu, 07/11/19 - 05:25 pm
patents
Amgen
Sanofi
Regeneron
Germany
Praluent
Repatha
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 04/28/19 - 10:00 pm
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
Praluent's lower list price isn't yielding better sales yet
Biopharma Dive
Sun, 04/28/19 - 12:36 pm
Sanofi
Regeneron
Praluent
drug pricing
U.S. FDA approves expanded label for Regeneron/Sanofi's cholesterol drug
Yahoo/Reuters
Sat, 04/27/19 - 10:20 am
Regeneron
Sanofi
Praluent
MACE
FDA
Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen
Biopharma Dive
Mon, 02/11/19 - 12:23 pm
Regeneron
Sanofi
Amgen
Praluent
Repatha
drug pricing
PCSK9 inhibitors
Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Fierce Pharma
Thu, 08/9/18 - 03:57 pm
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Supreme Court
Praluent
Repatha
Are These Disappointing Drugs Back on Track to Billions?
Motley Fool
Sun, 05/6/18 - 01:33 pm
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
Praluent
Repatha
3 Reasons Regeneron Stock Could Start Climbing Again
Yahoo/Motley Fool
Sun, 05/6/18 - 01:14 pm
Sanofi
Regeneron
Praluent
Dupixent
Eylea
Express Scripts Picks Regeneron Over Amgen, Cuts Heart Drug Price
Xconomy
Tue, 05/1/18 - 09:59 am
Regeneron
Sanofi
Express Scripts
PBMs
Praluent
drug pricing
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Fierce Pharma
Tue, 03/13/18 - 09:30 pm
Amgen
Repatha
Sensipar
generics
Sanofi
Regeneron
Praluent
Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?
Yahoo/Reuters
Sun, 03/11/18 - 11:50 am
Regeneron
Sanofi
Praluent
insurers
clinical trials

Pages